VERRICA PHARMACEUTICALS INC (VRCA) Stock Cash Flow
NASDAQ:VRCA - Nasdaq - US92511W1080 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -65.99M | -76.58M | -67.00M | -24.49M | -35.08M | |||
| Depreciation Amortization | 1.21M | 1.27M | 836.00K | 450.00K | 240.00K | |||
| Change In Working Capital | -48.00K | 2.03M | 9.86M | -1.80M | -540.00K | |||
| Interest Paid | 6.92M | 7.23M | 3.15M | 1.79M | 2.85M | |||
| Other non cash items | 11.17M | 12.36M | 17.72M | 7.18M | 7.79M | |||
| OPERATING CASH FLOW | -53.66M | -60.93M | -38.58M | -18.65M | -27.58M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -27.00K | -362.00K | -300.00K | -880.00K | |||
| Other Investing Activity | N/A | 8.00K | 0.00 | 54.34M | -120.00K | |||
| INVESTING CASH FLOW | N/A | -19.00K | -362.00K | 54.04M | -1.00M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -5.46M | -2.06M | 44.08M | -43.75M | 4.97M | |||
| Stock Issued/Repurchased | 39.79M | 39.79M | 30.31M | 26.90M | 28.68M | |||
| Other Financing Activity | N/A | 0.00 | -176.00K | -20.00K | 0.00 | |||
| FINANCING CASH FLOW | 34.33M | 37.73M | 74.21M | -16.87M | 33.65M | |||
| CHANGE IN CASH | -19.34M | -23.22M | 35.27M | 18.52M | 5.07M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -53.66M | -60.93M | -38.58M | -18.65M | -27.58M | |||
| Capital Expenditure | N/A | -27.00K | -362.00K | -300.00K | -880.00K | |||
| FREE CASH FLOW | -53.68M | -60.95M | -38.94M | -18.95M | -28.46M | |||
All data in USD